Informazioni sul prodotto
Nome:
Sovaprevir
Sinonimi:
- 2-Pyrrolidinecarboxamide
- ACH 0141625
- 2-Pyrrolidinecarboxamide, N-[(1R,2S)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-1-[(2S)-3,3-dimethyl-1-oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]butyl]-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-, (2S,4R)-
Descrizione:
Sovaprevir is a protease inhibitor that blocks the activity of NS3, an enzyme involved in the replication of the hepatitis C virus. It binds to the active site of NS3 and prevents cleavage of NS3-specific substrates. Sovaprevir also inhibits viral kinetics by binding to the envelope protein gp41 on the surface of HIV. Sovaprevir is an orally administered drug that can be used for treatment or prevention of both chronic and acute hepatitis C, as well as HIV infection. Sovaprevir is a potent inhibitor of serine proteases, including HIV protease, and has anti-cancer properties.
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:
Proprietà chimiche
Purezza:
Min. 95%
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
